Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
TransAlgae
TransAlgae Overview
TransAlgae develops an algae-based platform for the oral delivery of drugs (vaccines, immune modulators, insecticides, etc.) for human and animal health and for crop protection.
TransAlgae's drug-delivery platform was demonstrated on mice as a model for humans. TransAlgae successfully demonstrated that proteins, expressed in algae, were orally delivered to the mice blood and liver in their intact form, due to the native bio-encapsulation of the algae and the formulation that TransAlgae has developed.
In the area of animal health, TransAlgae's oral-delivery technology replaces the need for antibiotics and vaccination by injections. The company's algal powder, containing the desired drug or vaccine, is used as a feed supplement, enabling vaccination by feeding.
TransAlgae has also developed a proprietary platform for the delivery of biological-based insecticides to be sprayed on crops. The technology enables targeting particular insects in a specific manner, replacing the need for toxic chemicals.
The genetically modified algae are inactive, thus not affecting humans, animals, or crops, and are classified as a GMO-derived material.